BioSpace News Archive

IceCure Medical Ltd today announced that on January 13-14, 2023, the Company participated in the American Society of Breast Surgeons (“ASBrS”) Breast Fellows Ultrasound Course in Cincinnati, Ohio.

Inhibikase Therapeutics, Inc. today announced the U.S. Food and Drug Administration (“FDA” or “Agency”) has lifted the full Clinical Hold on IkT-148009 in Parkinson’s disease (PD).

Forge Biologics today the addition of three key leadership hires to further the Company’s growth as a leading manufacturer of genetic medicines.

Nascent Biotech, Inc. announced the completion of the dosing period of their Phase I Clinical Trial evaluating the safety and dose tolerance of Pritumumab as a treatment for Brain Cancer.

Electromedical Technologies, Inc. (OTC-QB: EMED) (“Electromedical” or the “Company”) and Sika Health, an HSA/FSA payment facilitator for eCommerce merchants, are pleased to announce a partnership enabling the direct acceptance of HSA/FSA payments on the Electromedical eCommerce website (electromedtech.com).

TOMI Environmental Solutions, Inc.® announces that TOMI will present its SteraMist brand of products at three upcoming International Society for Pharmaceutical Engineering (ISPE) Conferences in the first quarter of 2023.

AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC) announced that in December 2022 and January 2023, the Company signed definitive investment agreements with several third party investors.

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved ODACTRA® (House Dust Mite Allergen Extract) Tablet for Sublingual Use for the treatment of house dust mite (HDM)-induced allergic rhinitis in persons ages 12 through 17.

Newsight Imaging Ltd., a leading semiconductor innovator developing proprietary 3D machine vision sensors, spectral vision chips and systems, will present at Drive TLV Smart Mobility Events being held at the Hub at Stanford Research Park Luxe in Palo Alto, CA on January 30, 2023 and at the Coda Building, Georgia Tech in Atlanta, GA on February 1, 2023.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., will retire from his position as Chief Executive Officer (CEO), effective April 3, 2023.